Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px
Document › Details

Kiadis Pharma N.V.. (5/30/19). "Press Release: Kiadis Pharma Launches a Private Placement of New Shares to Raise approximately EUR 25 Million [Not for US, AU, CA, JP, ZA, et al.]". Amsterdam.

Organisations Organisation Kiadis Pharma N.V. (Euronext: KDS)
  Group Kiadis (Group)
  Organisation 2 Piper Jaffray & Co. (NYSE: PJC)
  Group Piper Jaffray (Group)
Products Product ATIR101™ (Kiadis)
  Product 2 investment banking
Index terms Index term Kiadis–SEVERAL: investment, 201905 private placment €27.6m with 3.68m new shares at €7.5/share
  Index term 2 CytoSen Therapeutics–Kiadis: investment, 201904– acquisition merger in shares with 1.94m shares (7.4%) upfront plus 5.82 shares milestones
Persons Person Sullivan, Amy (Kiadis 201901– SVP Corporate Affairs before Keryx Biopharmaceuticals + AMAG Pharmaceuticals + Idenix)
  Person 2 Clark, Mary (Optimum Strategic Communications 201710 before Hume Brophy + M:Communications + Capital MSL)
     


   
Record changed: 2019-06-06

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x112px

More documents for Kiadis (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px




» top